eCARTv5 Clinical Deterioration Suite (eCART) vs OpenEvidence

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

OpenEvidence

by OpenEvidence

AI Verdict

While both are AI-powered clinical decision support tools that integrate with EHRs, their primary functions differ significantly. eCARTv5 focuses on continuously predicting clinical deterioration in hospitalized patients to guide proactive care, whereas OpenEvidence provides immediate, evidence-based answers to clinical queries and assists with documentation. They address distinct aspects of clinical workflow and decision-making.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 if your primary goal is to proactively prevent clinical deterioration in hospitalized adult patients. This tool excels at continuous, AI-powered risk assessment, providing early warnings and guiding care with embedded clinical pathways to minimize critical events like ICU transfers or death. It's ideal for institutions seeking to enhance patient safety through predictive analytics and streamlined intervention protocols.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose OpenEvidence if…

Choose OpenEvidence if your priority is immediate access to evidence-based medical knowledge at the point of care, coupled with efficient clinical documentation. This platform is best suited for clinicians who need quick, referenced answers to complex clinical queries from peer-reviewed literature and desire AI assistance in transcribing patient visits and generating structured medical notes. It's particularly valuable for supporting diagnostic and treatment decisions while reducing documentation burden.

View OpenEvidence →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	OpenEvidence
Pricing	Contact vendor for tailored quote.	Free
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud-based (web application) and mobile applications
FDA Status	1 AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

OpenEvidence

While both tools aim for seamless integration, OpenEvidence offers broader accessibility through web and mobile applications in addition to EHR integration. Its 'Visits' feature, which transcribes patient encounters and auto-generates notes, directly addresses a significant clinician pain point, despite some reported quirks with speed and writing style.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

eCARTv5 has a more direct and measurable clinical impact, being an FDA-cleared Software as a Medical Device (SaMD) specifically designed to predict life-threatening clinical deterioration (death or ICU transfer) with strong prospective validation data. OpenEvidence provides valuable evidence-based information, but its impact on patient outcomes is more indirect, primarily reinforcing physician decisions rather than directly altering care pathways for critical events.

Pricing & Value

OpenEvidence

OpenEvidence offers a clear and immediate value proposition by being free for verified U.S. healthcare professionals, which has led to widespread adoption. In contrast, eCARTv5 requires contacting the vendor for a tailored quote, implying a potentially higher, enterprise-level cost without public transparency.

Enterprise Readiness

eCARTv5 Clinical Deterioration Suite (eCART)

eCARTv5's FDA clearance as a SaMD for a critical hospital function, its deep integration with EHRs to process up to 97 variables in real-time, and its robust reporting and benchmarking capabilities demonstrate a more mature and deeply embedded enterprise solution for managing patient populations and improving hospital-wide outcomes. While OpenEvidence offers enterprise models and EHR integration, its primary focus and widespread adoption are currently as a free tool for individual clinicians.

Innovation

OpenEvidence

OpenEvidence demonstrates greater innovation through its advanced natural language processing for direct clinical queries, automated clinical note generation, and features like 'Deep Consult' for complex reasoning. These applications of generative AI directly enhance daily clinical workflows and information retrieval in a novel way, going beyond predictive analytics.

Support & Docs

Tie

Neither the structured facts nor the web search results provide sufficient specific details about the breadth, depth, or responsiveness of support and documentation for either tool. While both likely offer some level of support, there's no clear differentiator to declare a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	OpenEvidence
Name	eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d)	OpenEvidence
Company	AgileMD	OpenEvidence
Tagline	AI-powered clinical decision support for better healthcare outcomes and efficiency.	America's Official Medical Knowledge Platform
Primary Function	Continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	AI-powered clinical decision support platform providing physicians with immediate, referenced answers from peer-reviewed medical literature and offering tools for clinical documentation.
Key Features	AI-powered clinical deterioration prediction; Continuous patient risk assessment (death or ICU transfer); EHR integration with real-time data (up to 97 variables); Embedded clinical pathways for care guidance; Early warning system (alerts hours before critical illness); Risk stratification (eCART score and risk designation); Minimizes false alarms and clinician workload; Reporting and benchmarking capabilities	AI-powered natural language question answering for clinical queries; Answers grounded in peer-reviewed medical evidence (NEJM, JAMA, NCCN, Cochrane, PubMed); Fully referenced answers with transparent sourcing to primary studies and guidelines; Clinical decision support at the point of care for high-stakes decisions; OpenEvidence Visits: transcribe patient visits and auto-generate structured medical notes; Real-time clinical decision support integrated into documentation workflows; Integrates with Electronic Health Record (EHR) systems like Epic; Official AI Partner of The New England Journal of Medicine, JAMA, NCCN, and Cochrane

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and OpenEvidence.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in the clinical problem each tool addresses?

AgileMD's eCARTv5 focuses on predicting the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients. OpenEvidence, on the other hand, provides immediate, referenced answers to clinical queries from peer-reviewed medical literature and offers tools for clinical documentation.

How do these tools integrate with existing Electronic Health Record (EHR) systems?

AgileMD's eCARTv5 is a cloud-based SaaS that integrates directly into EHR systems, utilizing up to 97 real-time variables for continuous patient risk assessment. OpenEvidence also integrates with EHR systems, including Epic, to provide real-time clinical decision support within documentation workflows.

How do these tools ensure the reliability and evidence base of their outputs?

AgileMD's eCARTv5 is an FDA-cleared SaMD that uses a machine learning algorithm trained on a multi-center dataset of over 800,000 patient records and validated with nearly two million hospitalizations to predict clinical deterioration. OpenEvidence's AI-powered answers are grounded in peer-reviewed medical evidence from sources like NEJM, JAMA, NCCN, Cochrane, and PubMed, providing fully referenced answers with transparent sourcing to primary studies and guidelines.

What additional functionalities do these tools offer beyond core decision support?

AgileMD's eCARTv5 provides reporting and benchmarking capabilities and is designed to minimize false alarms and clinician workload. OpenEvidence offers 'OpenEvidence Visits' to transcribe patient visits and auto-generate structured medical notes, and can also draft prior authorization letters and patient handouts.